Health in Guyana

1,092 indicators covering health for Guyana.

IndicatorLatest Year10-yr change Rank
Cases started on MDR-TB treatment 9 2024 up 125.0% 123rd
Share healthy diet unaffordable 4.9 2024 down 88.1% 118th
Number of people diagnosed with new episode of pulmonary TB who are ba 295 2021 down 8.7% 128th
Raised fasting blood glucose (>=7.0 mmol/L) 10.9 2014 up 32.9% 56th
Mean fasting blood glucose (mmol/l) 5.74 2014 up 5.6% 47th
Raised fasting blood glucose (>= 7.0 mmol/L) 9.1 2014 up 42.2% 78th
Reported number of people requiring interventions against NTDs 588,310 2024 down 18.2% 70th
Child deaths from streptococcus by disease 1 2015 down 66.7% 126th
Births attended by skilled health personnel 98.0% 2023 unchanged 93rd
Percentage of total deaths due to NCDs overall and percentage of total 44.02 2021 up 91.3% 41st
Number of new leprosy cases 16 2024 down 42.9% 80th
Low birth weight prevalence 17.2% 2020 up 1.8% 17th
Inactivated first-dose polio vaccine (IPV1) immunization coverage amon 99.0% 2025 up 219.4% 1st
Low birth weight number 2.8 2020 unchanged 121st
Number of new hivaids infections who 560 2024 up 12.0% 87th
Number of current cigarette smokers, estimate 41,000 2030 down 28.1% 148th
Incidence of malaria 38.74 per 1,000 population at risk 2024 up 31.0% 42nd
Reported number of children receiving antiretroviral therapy 75 2025 down 52.8% 80th
Concentrations of fine particulate matter 10.76 2023 down 16.2% 138th
Death rate road traffic injuries 22.3 2019 up 23.9% 58th
New or unknown treatment history cases: Pulmonary, bacteriologically c 222 2023 down 27.9% 139th
Medical doctors not further defined 1,032 2023 up 100.4% 94th
Life satisfaction vs life expectancy 70.18 2023 up 5.2% 168th
Estimate of current cigarette smoking prevalence 6.9% 2030 down 32.4% 120th
Estimate of current cigarette smoking prevalence (%) 7.3% 2030 down 33.0% 118th
Tb patients tested positive for hiv 65 2021 down 67.3% 91st
Number of children aged 6-59 months with anaemia 21.85 2019 down 19.9% 154th
Prevalence of anaemia in children aged 6-59 months 29.3% 2019 down 20.6% 92nd
Number of deaths attributed to non-communicable diseases, by type of d 684.96 2019 up 31.7% 156th
Hepatitis B surface antigen (HBsAg) prevalence 0.1% 2024 unchanged 101st
Mean hemoglobin level of children aged 6-59 months 116 2019 up 1.8% 103rd
Estimated number of MDR/RR-TB incident cases 15 2024 down 50.0% 135th
Mortality caused by road traffic injury 22.3 per 100,000 population 2019 up 42.9% 58th
Mortality caused by road traffic injury, female 5.6 per 100,000 female population 2019 up 16.7% 106th
Mortality caused by road traffic injury, male 38.9 per 100,000 male population 2019 up 46.2% 39th
Ipv vaccine coverage 99 2024 up 219.4% 1st
Tb patients living with hiv receiving art 53 2021 down 67.9% 87th
HIV-positive TB patients on ART (antiretroviral therapy) 70.0% 2024 unchanged 125th
Hospital beds 32.38 2023 up 88.3% 56th
Treatment success rate for patients treated for MDR-TB 33.0% 2022 down 67.0% 151st
New leprosy case detection rate per 1 000 000 population 19.25 2024 down 44.7% 29th
Treatment success rate: HIV-positive TB cases 63 2023 unchanged 113th
Prevalence of wasting, weight for height 6.5% 2019 up 18.2% 31st
Bladder cancer death rate 0.6127 2020 down 64.7% 102nd
Cancer death rates by type who db 0.6127 2020 down 64.7% 102nd
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) i 99.0% 2025 β€” 1st
International Health Regulations core capacity scores, SPAR version, 2 40 2025 β€” 112th
Prevalence of underweight, weight for age 9.4% 2019 down 14.5% 52nd
Leprosy registered prevalence rate per 1 000 000 population 20.45 2024 down 71.7% 33rd
Leprosy - Number of new leprosy cases among children 0 2024 down 100.0% 69th
Leprosy - Number of cases registered for treatment 17 2024 down 70.7% 78th
New leprosy child case detection rate (less than 15 years of age) per 0 2024 down 100.0% 69th
Children (0-14) living with HIV 500 2024 unchanged 66th
Ipv1 number unvaccinated 165.32 2023 down 98.5% 168th
Children living with hiv 500 2024 unchanged 66th
Contraceptive prevalence, any method 29.9% 2020 down 29.7% 93rd
Children (ages 0-14) newly infected with HIV 100 2024 unchanged 51st
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 β€” 3rd
Liver cancer death rate 5.35 2020 up 62.1% 20th
Number of children newly infected with hiv 100 2024 unchanged 51st